ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Tobacco Council Awards 34 New Grants

April 16, 1982

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

Moratorium Asked On New Bladder Cancer Screening

January 27, 1978

More Than 300 request RFP for New Community Oncology Program

May 25, 1979

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981